Press Release: Avantor(R) Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

Dow Jones
05/19

RADNOR, Pa., May 19, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.

In this role, Mr. Porreca is responsible for leading quality assurance, quality systems and regulatory affairs globally across all Avantor's businesses.

Mr. Porreca is an accomplished executive with deep quality, regulatory affairs, and compliance experience across the life sciences, medical technology, and healthcare industries. He joins Avantor from Getinge, where he led the Quality and Regulatory organization through global product approvals, complex regulatory engagement, and transformation initiatives across the U.S., EU MDR, and China. Prior to Getinge, he held senior executive roles at Becton Dickinson and Company, C.R. Bard, Inc., and Smith+Nephew plc.

"Delivering solutions that meet the highest standards of quality and reliability makes Avantor a trusted partner at every stage of the scientific journey," said Emmanuel Ligner, Avantor's President and CEO. "Jerry's deep expertise in global quality systems and complex regulatory landscapes will be vital as we continue to enhance and scale our operations and deliver mission critical solutions for our customers," Ligner concluded.

Mr. Porreca added, "In the life sciences and advanced technology sectors, quality and regulatory excellence are not just requirements--they are a key value proposition for our customers. I look forward to working with our global teams to further strengthen our quality systems and leverage data-driven insights to help our customers accelerate the delivery of life-changing breakthroughs to patients worldwide."

About Avantor

Avantor$(R)$ is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.

Global Media Contact

Valerie Collado

Director, Community Impact and Communications

Avantor

484-885-9338

Valerie.Collado@avantorsciences.com

Investor Relations Contact

Chris Fidyk

Vice President, Investor Relations

Avantor

Chris.Fidyk@avantorsciences.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/avantor-announces-gerard-jerry-porreca-as-executive-vice-president-quality-and-regulatory-302775278.html

SOURCE Avantor and Financial News

 

(END) Dow Jones Newswires

May 19, 2026 06:05 ET (10:05 GMT)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10